Genomic medicine brings significant opportunities which will change the provision of healthcare in Australia, from changes in diagnosis to targeted treatments. These opportunities bring challenges to the established practices of clinical research, regulatory process and reimbursement processes. This session explores developments in genomic medicine/technologies which will impact on Australian healthcare practice. Three speakers will provide background and context before a cross-disciplinary panel discussion on the opportunities and challenges of integrating of genomic medicine into the healthcare system, highlighting what this means for clinical research, regulatory and reimbursement professionals.
Chairperson: Nicholette Conway, GenomePlus and Eli Lilly
Forum: Panel Discussion on the challenges and opportunities facing Australia.